Search research articles
Contact Us
Filters
Showing results (401-410 of 634) with videos related to
Page
of 64
Sort By:
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study
Yoon-Koo Kang, Sung Sook Lee, Dok Hyun Yoon, et al.
Circulation
|
July 14, 2016
Diabetes-Induced Jagged1 Overexpression in Endothelial Cells Causes Retinal Capillary Regression in a Murine Model of Diabetes Mellitus: Insights Into Diabetic Retinopathy
Chang-Hwan Yoon, Young-Eun Choi, Young Ryun Cha, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
December 7, 2007
Metallic stent placement in patients with recurrent cancer after gastrojejunostomy
Ho-Young Song, Tae-Hyung Kim, Eugene K Choi, et al.
Medical Oncology (Northwood, London, England)
|
May 24, 2008
Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis
Byung Woog Kang, Tae Won Kim, Jae-Lyun Lee, et al.
Cancer Research and Treatment
|
July 8, 2016
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
Kyu-Pyo Kim, Jeong-Eun Kim, Yong Sang Hong, et al.
World Journal of Surgery
|
December 29, 2017
Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer
Sung Min Jung, Yong Sang Hong, Tae Won Kim, et al.
Journal of Pediatric Orthopedics
|
May 9, 2013
Estimation of the recovery of physiological genu varum with linear mixed model
Bekhzad Akhmedov, Soyeon Ahn, Chin Youb Chung, et al.
Toxicologic Pathology
|
June 23, 2026
New Modalities and Carcinogenicity Assessment
Emily K Meseck, Paul Batty, Tae-Won Kim, et al.
Oncology Reports
|
November 15, 2021
Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance
Eunyoung Tak, Minhee Kim, Youngra Cho, et al.
Future Oncology (London, England)
|
September 13, 2023
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer
Thierry André, Filippo Pietrantonio, Antonio Avallone, et al.
Page
of 64
Search research articles
Search
Showing results (401-410 of 634) with videos related to
Sort By:
Page
of 64
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 14, 2010
Pyridoxine is not effective to prevent hand-foot syndrome associated with capecitabine therapy: results of a randomized, double-blind, placebo-controlled study
Yoon-Koo Kang, Sung Sook Lee, Dok Hyun Yoon, et al.
Circulation
|
July 14, 2016
Diabetes-Induced Jagged1 Overexpression in Endothelial Cells Causes Retinal Capillary Regression in a Murine Model of Diabetes Mellitus: Insights Into Diabetic Retinopathy
Chang-Hwan Yoon, Young-Eun Choi, Young Ryun Cha, et al.
Journal of Vascular and Interventional Radiology : JVIR
|
December 7, 2007
Metallic stent placement in patients with recurrent cancer after gastrojejunostomy
Ho-Young Song, Tae-Hyung Kim, Eugene K Choi, et al.
Medical Oncology (Northwood, London, England)
|
May 24, 2008
Bevacizumab plus FOLFIRI or FOLFOX as third-line or later treatment in patients with metastatic colorectal cancer after failure of 5-fluorouracil, irinotecan, and oxaliplatin: a retrospective analysis
Byung Woog Kang, Tae Won Kim, Jae-Lyun Lee, et al.
Cancer Research and Treatment
|
July 8, 2016
Paired Primary and Metastatic Tumor Analysis of Somatic Mutations in Synchronous and Metachronous Colorectal Cancer
Kyu-Pyo Kim, Jeong-Eun Kim, Yong Sang Hong, et al.
World Journal of Surgery
|
December 29, 2017
Impact of a Multidisciplinary Team Approach for Managing Advanced and Recurrent Colorectal Cancer
Sung Min Jung, Yong Sang Hong, Tae Won Kim, et al.
Journal of Pediatric Orthopedics
|
May 9, 2013
Estimation of the recovery of physiological genu varum with linear mixed model
Bekhzad Akhmedov, Soyeon Ahn, Chin Youb Chung, et al.
Toxicologic Pathology
|
June 23, 2026
New Modalities and Carcinogenicity Assessment
Emily K Meseck, Paul Batty, Tae-Won Kim, et al.
Oncology Reports
|
November 15, 2021
Expression of neurofibromin 1 in colorectal cancer and cetuximab resistance
Eunyoung Tak, Minhee Kim, Youngra Cho, et al.
Future Oncology (London, England)
|
September 13, 2023
KEYSTEP-008: phase II trial of pembrolizumab-based combination in MSI-H/dMMR metastatic colorectal cancer
Thierry André, Filippo Pietrantonio, Antonio Avallone, et al.
Page
of 64